biowaiver for higher strength [Regulatives / Guidelines]

posted by wienui  – Germany/Oman, 2022-02-01 09:12 (115 d 07:02 ago) – Posting: # 22768
Views: 742

(edited by wienui on 2022-02-01 15:29)

Hi John,

» Based on the above, can I file a biowaiver for the higher strength test product so I don't have to run a PK BE study?

Are both strengths (low & high) follow the following EMA 5% & exceients rule?

Amount of API must be < 5% of tablet core weight, and
Amounts of excipients are same per strength, or
Only the amount of a filler is changed to account for changes in API weight.


Complete thread:

UA Flag
 Admin contact
22,108 posts in 4,630 threads, 1,567 registered users;
online 4 (0 registered, 4 guests [including 2 identified bots]).
Forum time: Friday 17:15 CEST (Europe/Vienna)

We absolutely must leave room for doubt
or there is no progress and no learning.
There is no learning without having to pose a question.
And a question requires doubt.
People search for certainty.
But there is no certainty.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz